Cargando…

Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer

PURPOSE: To explore if bexarotene (BEX) synergistically enhances docetaxel (DTX) cytotoxicity in castration-resistant prostate cancer cell lines. MATERIALS AND METHODS: MTT assay was used to measure the cytotoxic effect of DTX and BEX on castration-resistant prostate cancer (CRPC) cell proliferation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Danyang, Wang, Huan, Zheng, Qiming, Cheng, Sheng, Xu, Liwei, Wang, Mingchao, Li, Gong H, Xia, Li Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768013/ https://www.ncbi.nlm.nih.gov/pubmed/31576145 http://dx.doi.org/10.2147/OTT.S209307

Ejemplares similares

Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]
Publicado: (2019)

Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT‐20 cells
por: Xia, Liqun, et al.
Publicado: (2021)

A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours
por: Yen, W-C, et al.
Publicado: (2006)

Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
por: Shimizu, Masahito, et al.
Publicado: (2008)

Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression
por: Hu, Linyi, et al.
Publicado: (2019)

An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene
por: Jurutka, Peter W., et al.
Publicado: (2022)

Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARγ/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats
por: Zuo, Yuchun, et al.
Publicado: (2019)

A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats
por: Ren, Shuyue, et al.
Publicado: (2020)

Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin
por: Nosova, Yulia N., et al.
Publicado: (2017)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Of Retinoids and Organotins: The Evolution of the Retinoid X Receptor in Metazoa
por: Fonseca, Elza, et al.
Publicado: (2020)

The Retinoid and Non-Retinoid Ligands of the Rod Visual G Protein-Coupled Receptor
por: Ortega, Joseph T., et al.
Publicado: (2019)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

Photodegradation of Bexarotene and Its Implication for Cytotoxicity
por: Kryczyk-Poprawa, Agata, et al.
Publicado: (2021)

Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma
por: Morita, Akimichi, et al.
Publicado: (2022)

Preclinical PET Neuroimaging of [(11)C]Bexarotene
por: Rotstein, Benjamin H., et al.
Publicado: (2016)

Bexarotene improves motor function after spinal cord injury in mice
por: Wang, Xingyu, et al.
Publicado: (2023)

Retinoid X Receptor Antagonists
por: Watanabe, Masaki, et al.
Publicado: (2018)

Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer
por: Jiang, Sen, et al.
Publicado: (2018)

Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells
por: Lee, Sang-Han, et al.
Publicado: (2021)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Bexarotene-Induced Hypertriglyceridemia: A Case Report
por: Maminakis, Chris, et al.
Publicado: (2018)

Retinoic Acid and Retinoid X Receptors
por: Schubert, Michael, et al.
Publicado: (2023)

Role of noncoding RNA in drug resistance of prostate cancer
por: Ding, Lifeng, et al.
Publicado: (2021)

Cocrystal Prediction of Bexarotene by Graph Convolution Network and Bioavailability Improvement
por: Xiao, Fu, et al.
Publicado: (2022)

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
por: Han, Bin, et al.
Publicado: (2012)

The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice
por: Li, Y, et al.
Publicado: (2008)

Identification of Bexarotene as a PPARγ Antagonist with HDX
por: Marciano, David P., et al.
Publicado: (2015)

Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
por: Warda, Ankedo, et al.
Publicado: (2023)

Synergistic Antitumor Activities of Docetaxel and Octreotide Associated with Apoptotic-Upregulation in Castration-Resistant Prostate Cancer
por: Zhu, Sha, et al.
Publicado: (2014)

Synergistic Enhancement of Cancer Therapy Using a Combination of Ceramide and Docetaxel
por: Feng, Li-Xia, et al.
Publicado: (2014)

Liver X Receptor/Retinoid X Receptor Pathway Plays a Regulatory Role in Pacing‐Induced Cardiomyopathy
por: Lin, Yu‐Sheng, et al.
Publicado: (2019)

Bexarotene Gel: A New Topical Therapy for Alopecia Areata
por: Rajiv, Mahajan, et al.
Publicado: (2010)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
por: Tousi, Babak
Publicado: (2015)

Bexarotene: A Rare Cause of Misleading Thyroid Function Tests
por: Pattan, Vishwanath, et al.
Publicado: (2020)

FRI511 Bexarotene: A Deceptive Cause Of Iatrogenic Hypothyroidism
por: Ghaith, Sarah, et al.
Publicado: (2023)

Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer
por: Dai, Liang, et al.
Publicado: (2021)

Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
por: Shimizu, Masahito, et al.
Publicado: (2012)

The Crucial Involvement of Retinoid X Receptors in DDE Neurotoxicity
por: Wnuk, A., et al.
Publicado: (2015)

Dissecting myogenin-mediated retinoid X receptor signaling in myogenic differentiation
por: Khilji, Saadia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rn5ir2t0qrnik1vhku9kfsspbd